Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2022 Sep:59:182-183.
doi: 10.1016/j.ajem.2022.04.051. Epub 2022 May 10.

Atrial fibrillation in COVID-19 patients receiving remdesivir, matched case-control analysis

Petra Bistrovic  1 , Sime Manola  2 , Ivan Papic  3 , Ana Jordan  1 , Maja Ortner Hadziabdic  4 , Marko Lucijanic  5
Affiliations
Comment

Atrial fibrillation in COVID-19 patients receiving remdesivir, matched case-control analysis

Petra Bistrovic et al. Am J Emerg Med. 2022 Sep.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest The authors declare that they have no conflict of interest.

Figures

Fig. 1
Fig. 1
In-hospital mortality stratified according to remdesivir use and the presence of atrial fibrillation.
Fig. 2
Fig. 2
In-hospital mortality stratified according to the presence of atrial fibrillation and remdesivir use considering the level of oxygen demand at the time of remdesivir application: A) before high flow oxygen therapy (HFOT) or mechanical ventilation (MV) requirement, B) during HFOT and C) during MV.
See this image and copyright information in PMC

Comment on

References

    1. Chen M.Y., Xiao F.P., Kuai L., Zhou H.B., Jia Z.Q., Liu M., et al. Outcomes of atrial fibrillation in patients with COVID-19 pneumonia: a systematic review and meta-analysis. Am J Emerg Med. 2021;50:661–669. doi: 10.1016/j.ajem.2021.09.050. - DOI - PMC - PubMed
    1. Touafchia A., Bagheri H., Carrié D., Durrieu G., Sommet A., Chouchana L., et al. Serious bradycardia and remdesivir for coronavirus 2019 (COVID-19): a new safety concerns. Clin Microbiol Infect. 2021 doi: 10.1016/j.cmi.2021.02.013. - DOI - PMC - PubMed
    1. Bistrovic P., Manola S., Lucijanic M. Bradycardia during remdesivir treatment might be associated with improved survival in patients with COVID-19: a retrospective cohort study on 473 patients from a tertiary Centre. Postgrad Med J. 2021 doi: 10.1136/postgradmedj-2021-141079. - DOI - PubMed
    1. Bistrovic P., Lucijanic M. Remdesivir might induce changes in electrocardiogram beyond bradycardia in patients with coronavirus disease 2019-the pilot study. J Med Virol. 2021;93(10):5724–5725. doi: 10.1002/jmv.27177. - DOI - PMC - PubMed
    1. Beigel J.H., Tomashek K.M., Dodd L.E., Mehta A.K., Zingman B.S., Kalil A.C., et al. Remdesivir for the treatment of COVID-19 - final report. N Engl J Med. 2020;383(19):1813–1826. doi: 10.1056/NEJMoa2007764. - DOI - PMC - PubMed

MeSH terms